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In 1921 Litzenbergl~pplied the term missed abortion to all 
cases of death of the fetus in utero before viability with no 
effort at expulsion within the usual time of an ordinary abortion, 
the expulsion considered occurring up to 8 weeks after death. 
Eastman, 1961, defines a missed abortion as the retention, 
two months or more after its death, of an early intra-uterine 
pregnancy. 
Litzenberg states that in his cases hemorrhage 'V,as a prom-
inent finding, giving the ovum a hemorrhagic a:fJpearance; but 
hemorrhage may be entirely absent. He noted that in the placenta 
infarcts were numerous, sometimes occupying neal°ly the whole 
organ, suggesting the probable cause of fetal death. One of the 
great dangers of missed abortion, he thought, was due to degen-
eration of the blood vessel walls which could be so completely 
destroyed that uncontrollable hemorrhage could occur. Disap-
pearance or marked diminution of the amniotic fluid without 
rupture of the membrane was the rule. 
He noticed the frequency of discrepancy between the size 
of the placenta ~~d the fetus, the former being often as large 
as the placenta of a fetus a month or more older than the one 
found. This was considered to be due to connective tissue 
increase, hemorr1">..age into the placenta and a curious true growth 
of the placenta after the death of the fetus. He felt that when 
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the fetus died, especiallY in the early weeks, the chorion and 
decidua may go on growing because they are nourished by the 
maternal blood circulating in the intervillous spaces which may 
continue for a long time. LaVerge observed karyokinesis indi-
cating cell multiplication rather than hypertrophy. He noticed 
that the inner layer of the villous epithelium, which is not in 
direct contact with maternal blood, is an early victim to coag-
ulation necrosis; but the outer syncytial layer, bathed in mater-
nal blood, is preserved much longer until thrombosis takes place 
shutting off the blood supply to the intervillous spaces. In 
the second half of pregnancy Von Franque asserted that this 
interesting phenomenon of continued growth after the death of 
the fetus did not occur. Microscopic studies showed all stages 
of necrosis of tissue, placenta, decidua, amnion, blood vessels. 
the fetus and even uterine walls. If the o~~ remained in the 
uterus for a long time, drying out or mummification occurred. 
By Litzenberg's definition, the symptoms of miSsed abortion 
are lack of increase in size of the uterus, cessation of fetal 
movements and other signs of pregnancy. Regression changes in 
the breasts also take place. Hemorrhage is a very inconstant 
accompaniment of missed abortion, but in some form or another it 
usually complicates the condition, sometimes constituting a 
great danger. 
Eastmanlbviews the cases of missed abortion as follows. 
He states that in the typical instance, the first few months of 
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pregnancy are completely normal: amenorrhea. nausea and vom-
iting. breast changes, and gro",th of uterus. All goes well 
until the ovum dies, when there mayor may not be vaginal bleed-
ing or even sY".llptoms denoting a threatened abortion, which sub-
side. It is then noted that the uterus seems to remain sta-
tionary in size and the breasts regress. The patient is likely 
to lose a fe"t pounds in \<leight. Careful palpation and. measure-
ment of the uterus reveal the fact that it has not only ceased 
to enlarge but is growing smaller, from the absorption of 
amniotic fluid and maceration of the fetus. Most patients are 
symptomless during this period, except for the persistence of 
amenorrhea. Some, ho,.,ever, complain of lassitude and depress ion. 
If the missed abortion terminates spontaneously, as most do, the 
process of expulsion is quite the same as in any ordinary abor-
tion. The product, if reta.ined several weeks after fetal death. 
is a shrivelled sac containing a highly macerated embryo, and 
if retained for months or years, it appep..I's to be a mass of old 
tissue and blood with areas of dense calcification. He states 
that the cause of missed abortion is not known • 
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N. E. Borglin (Sweden) stated in 1957, that there is 
nothing essential to distinguish ~issed abortion with a demon-
strable embryo from an abortion occurring after more than 8 
weeks in which the embryo has been absorbed. The duration of 
retention is often difficult to assess because it is not easy 
and is often impossible to decide whether the embryo t~s died. 
The strikingly large number of ordinary abortions suggests 
that a missed abortion is only a variety of ordinary abortion. 
It is suggested that the term missed abortion be reserved for 
fetal death after the fourth month of pregnancy with retention 
of the dead fetus for at least six weeks. ~~ny prefer con-
servative treatment, in other words, waiting for a spontaneous 
abortion, especially because of the risk of hemorrhage in surg-
ical intervention, which is partly due to the frequently poor 
contractile power of the uterus in this condition. This inad-
equate power of contraction probably also causes retention 
of the dead ovum. Spontaneous abortion usually occurs ,,!ith 
only slight loss of blood. because at this stage the vessels 
of the uterine endometrium have thrombosed and the uterus has 
recovered its power of contraction. The severe loss of blood 
on surgical evacuation of the uterine cavity and the copious 
bleeding sometimes accompanying spontaneous abortion, can 
occasionally be ascribed in part to hypofibrinogenemia. 
The characteristic features of a missed abortion are 
considered as low spontaneous myometrial activity, low oxy-
tocin sensitivity and danger of bleeding after surgical inter-
vention mainly due to atony, but sometimes to afibrinogenemia. 
In view of the inactive state of the myometrium, which is often 
thin and fragile, and of the successful estrogen treatment of 
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a big gr~~p of missed abortions, it is felt that it is justi-
fied to conclude that lack of estrogen is an etiologic factor. 
rt 
Cassmer has sho~m that when the fetus dies and the placenta 
is undamaged, the conditions predispose to mis.sed abortion. On 
the basis of these findings, it was hypothesized that human 
spontaneous missed abortion is due to fetal death and the conse-
quent changes in the hormone production of the relatively undam-
aged placenta. ]'or a time after fetal death, the myometrium 
remains progesterone dominated (Stage 1), and effective activity 
cannot develop. Sooner or later, placental hormone production 
ceases; and bein.g devoid of both hormones, the myometrium is 
"castrated" (or at least "non-pregnant") a.'1d unable to work 
(Stage 2). Estrogen domination will not occur until the myo-
metrium is again stimulated by estrogen, either produced by the 
ovaries or given therapeutically. The etiology provides a clue 
to its treatment. In Stage 1. treatment with estrogen and oxy-
tocin has no effect. Destruction of placental function alone 
(e.g. by intrauterine injection of hypertonic solution) removes 
the progesterone block. Estrogens may be useful, though they 
may not be necessary. Stage 2. estrogen alone usually starts 
the abortion a.'1d surgical intervention is rarely necessary. 
The validity of this theory of the etiology and treatment 
of missed abortion was tested by these workers in thirteen con-
secutive patients. To accelerate abortion in seven of the thir-
teen patients, oxytocin was given as an I.V. drop. The purpose 
of estrogen treatment in Stage 2 was to build up a potent 
myometrium from a, IIcastrated" state and this necessarily 
takes several days. The estrogen, therefore, should be con-
tinued for 6 - 10 days. If abortion has not occurred after 
ten days, the hormonal state should be rechecked. 
Their hypothesis of missed abortion was supported by 
the fact that two stages. characterized by different hormonal 
condition, could be distinguished and that selected treatment 
Was successful on all yatients. 
Roland\oticed that almost all patients who aborted had 
falling or 10'" urinary hormone excretion before the onset of 
bleeding or other disturbances. When the preconceptional 
endometrium showed poor premenstrual secretory activity and 
urinary hormone excretions were correspondingly low, substi-
tutional endocrine therapy during pregnancy appeared to salvage 
a sizable percentage of pregnancies. When the preconceptional 
endometrium sho1rled poor secretory ~tctivity and normal levels 
of urinary hormone excretion, endocrine treatment during preg-
nancy had no effect. When urinary hormone excretion levels, 
particularly those of estrogen and pregnanediol were normal at 
onset of bleeding, percentage of pregnancies with a favourable 
outcome was much greater. Workers who feel that a considerable 
percentage of spontaneous abortion is due to maternal factors. 
have found hormone determinations of substantial importance. 
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Cassmer reported in 1959 that in therapeutic abortions 
in mid-pregnancy he ruptured the membranes and pulled down 
the umbilical cord, which was ligated and cut. The foetus 
and the placenta were left in the uterus for three days and 
then they were removed tll.l"ough the cervix. In these cases 
with "isolated placentae" the urinary excretion of estrogens 
decreased rapidly. Three days after fetal death the urinary 
estrogens had fallen to )0% of their previous value, and the 
estrogens in the placenta had disappeared. Some workers be-
Heve that the fetus may be responsible for estrogen pro-
duction. On the other hand, pregnanediol fell much less and 
after three days, the output 'vas still 87% of the previous 
value. During these three days no uterine activity was ob-
served. This indicates that if the foetus dies before the 
placenta, the production of estrogen ceases before that of 
progesterone. Because Cassmer removed the whole conceptus 
after three days, we do not kno~l from his studies how rapidly 
and to what levels the production of estrogen and progesterone 
may fall later. 
When the fetus and placenta die simultaneously, as in 
saline-induced abortions, the placental production of estro-
gen and progesterone falls rapidly and simultaneously. The 
withdrawal of progesterone which affects only the excitability 
of the myometrium, acts more quickly than does the withdrawal 
of estrogens, which has the slower task of building up the 
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myometrium. Then, when placental function is abruptly des-
troyed. the effect of progesterone on the myometrium is domi-
nated by estrogen for a timeCIi'ig. 1). 
Fig. 1 
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Under these conditions, contractions start and abortion is 
rapidly completed, thus, missed abortion does not develop. 
The mechanism must be similar in spontaneous abortions where 
fetal death is a consequence of placental death. On these 
findings was based the hypothesis that human spontaneous 
missed abortion is due to fetal death and the consequent 
changes in the hormone production of the relatively undamaged 
placenta. For a time after fetal death the myometrium re-
mains progesterone dominated, and effective activity cannot 
develop. Sooner or later placental hormone production ceases; 
and, being devoid of both hormones, the myometrium is virtually 
"ca.strated ll and unable to ,",ork. 
Dr. M. Doyle states that daily determinations of the 
urinary excretion of pregna.nediol and estriol before and after 
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intrauterine death in missed abortion showed that estriol 
excretion falls well before pregnandiol excretion. If the 
hypothesis is correct, two stages of missed abortion should 
be found: 
Stage 1. with a progesterone dominated myometrium resulting 
from partial functioning of the placenta, and 
characterized by slight reduction of pregnanediol 
and greater reduction of estrogen excretion. 
Stage 2. in which the myometrium is "castrated," charac-
terized by severe reduction of both estrogen and 
pregnanediol excretion. 
It is not kno~n how long after fetal death, placental pro-
gesterone production can be maintained. The time after fetal 
death, therefore. does not necessarily indicate in which sta.ge 
a case is. 
The hormonal function of the placenta in missed abortion 
is not fully UIJ.derstood. Pregnancy tests. based on the chor-
ionic gonadotrophins in the urine. are often negative but 
sometimes positive. The excretion of urinal'S pregnanediol 
is often 10\>1 but occasionally normal or only slightly reduced. 
The urinary excretion of estrogen is very low, thus the hor-
monal function of the placenta, judged by the urinary excretion 
of these three hormones, is often severely impaired, though 
occasionally this impairment is only slight. 
i'ff.> ..... 
Stouffer and Asch~rorth believe that patients with intra-
uterine retention of a dead fetus are potentia.l ca,.Y1didatea for 
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development of hypofibrinogenemia. This disease results from 
a consta.nt process of laying o.own of fibrin in the intervillous 
spaces of the placenta in the dead fetus syndrome and from 
local deposition of fibrin at the site of placental separation 
in cases of abr1~tio placenta. 
Beginning \,lith the third \I,reek after apparent fetal death, 
the concentration of fibrinogen in the plasma should be deter-
mined weekly. It is postulated that the fetus that is at least 
thirteen weeks old. can develop the condition of hypofibrin-
ogenemia. If the concentration of fibrinogen falls below 
50 mg./100 ml., the uterus should be emptied prorL1ptly. At 
least 4 grams of human fibrinogen and several units of com-
patible whole blood should be immediately availa,ble. After 
emptying the uterus, close attention should be given to blood 
loss,from the vagir~. Present evidence. however, indicates 
that once the uterus is empty the process of defibrination 
ceases and hemostasis can be maintained without further admin-
iater of fibrinogen. 
i~ 
Zielinska (Poland, 1958) found four cases of hypofib-
rinogenemia in 20 pregnant women with a dead fetus. Ji'ibrin-
olysins were also found. These usually appe8.red four weeks 
after the moment of death of the fetus. The behavior of fibrin-
ogen and fibrinolysin levels in these women is characteristic. 
The fibrinogen level may remain high despite the presence of 
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fibrinolysins. Thanks to which the hypofibrinogenemia does 
not appear as often. During labor a considerable decrease 
in fibrinogen level takes place. After three hours, the level 
increases and after 24 hours it returns to normal. 
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PROGESTERONE AND PROGESTATIONAL AGENTS 
The main actions of progesterone are directed toward 
preparation of the uterus for reception of the fertilized 
ov~ and maintenance of a favorable environment for its growth 
arA development. Studying the biosynthesis and metabolism of 
progesterone and its interrelations with other steroid hor-
s 
mones, Plotz and Davis (Univ. of Chicago) found that cholesterol 
of two sources is available in an endocrine gland for syn-
thesis of progesterone: (1) cholesterol synthesized within 
the endocrin gland and (2) plasma cholesterol, which is derived 
from dietary cholesterol and cholesterol synthesized in the 
liver. the rate of absorption of plasma cholesterol by the 
corpus luteum and placenta was found to be efficient and rapid. 
Progesterone itself is not excreted into the urine, but its 
principal metabolite, pregr>...anediol, appears in large and. in-
creasing amounts in the urine of pregnant women, reaching peak 
values of 70-90 mg./24 hours during the last part of the third 
trimester. Pr egnaPAl one , another metabolite of progesterone, 
follows a similar excretion pattern. Progesterone secreted 
into the circulation from the glands disappears rapidly from 
the blood. Similarly, when progesterone is administered I.M. 
the hormone and/or its metabolites diffuse promptly from the 
blood circulation intc the fat compartment of the body. These 
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findi!1gs explain (1) the failure of large doses of proges-
terone injected I.M. to raise the blood level of progesterone 
and the ra.pid disappearance of progesterone from the blood 
after I. V. injection and (2) the delayed excret ion of proges-
terone metabolites after I.V. injection. 
if:-
The sources of endogenous progesterone are as follows: 
The ovaries, the adrenals, and in pregnancy the placenta are 
the sites of progesterone production in the female. 
The progesterone produced in the ovary comes primarily 
from the corpus luteum. The follo'tling biochemical results 
are presented as evidence (1) The relatively large a."'Ilounts 
of progesterone in human corpora lutea of the menstrual cycle 
and of pregnancy, (2) The increased pregnanediol excretion 
after formation of the corpus luteum, as well as the drop in 
pregnanediol after physiological repression or removal of 
the corpus luteum. 
Through the work of Rechter, it is known that proges-
terone occupies a key position in the 'biosynthesis of the 
adrenal cortical hormones. This does not necessarily mean 
that the adrenal cortex must secreter;>rogesterone, however, 
indication that secretion of the hormones may occur ~AS existed 
for some time. Olear cut evidence for the production of pro-
gesterone by human adrenal cortex was presented by Short, 
through the demonstration of progesterone in adrenocortical 
venous blood after AOTH stimulation. 
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There is no question now tr.at the human ple,centa pro-
duces progesterone. With the grollJth of the placenta. the pro-
gesterone production increases. Experi~ental evidence is: 
(1) Presence of progesterone in placental tissue at all 
phases of gestation; 
(2) Increase in progesterone concentration in arm vein 
blood during pregnancy, with rapid decrease after removal of 
the placenta; 
(3) Increase in pregnanediol excretion during pregnancy. 
Rapid decrease follows removal of the placenta; 
(4) Increase in pregnanediol concentration in the arm 
vein blood during pregnancy; 
(5) Increased :progesterone levels in fat tissue during 
pregnancy; 
(6) Yaintenance of pregnancy with abnormal pregnanediol 
excretion after removal of the corpus leteum or of the ovaries 
in early pregnancy; 
(7) ~ro initial change of pregnanediol excretion after 
operative removal of an abdominal pregnancy, the placenta 
being left in situ. After expulsion of the placenta in a 
normal delivery, pregnanediol excretion drops i~tediately; 
(8) Uo cr.ange of pregnanediol excretion after artifie:ially 
induced fetal death with the placenta left in situ. Rapid de-
crease following removal of the placenta; 
(9) Normal pregnanediol excretion in Addison's disease or 
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following bilateral adrenalectomy; thus the adrenals are not 
the main source of progesterone. 
(10) Higher levels of progesterone in the uterine venous 
blood than in peripheral venous blood at the end of pregnancy; 
(11) Higher levels of progesterone in the umbilical venous 
blood than in the blood of the umbilical arteries; 
(12) Presence of progesterone in a chorion epithelioma; 
(1)) Conversion of ~5 - pregnen.olone to progesterone by 
placental tissue in vitro; 
(14) Conversion of A 5 - pregnenolone and cholesterol to 
progesterone in pla.centalperfusion experiments. 
Effects of Progesterone on Endometrium 
The withdrawal of progesterone near term has been thought 
by many workers to be a factor for the onset of labor. Although 
few dispute the relaxing effect of progesterone on the myomet-
rium, the diminution either of progesterone in the blood or of 
its meta~olic products in the urine near labor has never been 
well established. In vitro studies in human pregnant and non-
pregnant myometrium have revealed that the i~~ibiting action of 
progesterone can be antagonized if enough oxytocin is added in 
the muscle bath. On the other hand oxytocin stimulated con-
tractions can be abolished if enough progesterone is added. 
Concernir~ the action of the progesterone on the end om-
15 
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etri~n. Erux noted: (a) The appearance of glycogen in the 
basal part of the cells of the glands (lucid zone) later at 
the apical part; (b) The forrmation of connective spindles with 
cellular "puffsll \,/hieh give a lacy aspect to the glands; (c) 
Oellular modification of the endometrial stroma, evidenced by 
a widening of the cytoplasm of the fibroblastic and reticular 
cells, especially in the superficial zone; Cd) and, surro~~ding 
these, grad.ually formed coiled arteries. 
These endometrial transformations appear progressively 
follow'ing ovulation, reaching their maximum at the 26th day of 
the cycle , with glycogen in pools in the lumen of the tubes and 
the appearance of a mucoid secretion in the cells. Hemorrhagic 
ruptures, marked edema and an invasion of polymorphonuclear 
leucocytes are the expression of the very near brea~ing down of 
the endometrium. Progesterone will produce certain morphologic 
changes in the endometrium only if there is adequate estrogen 
stimulation. 
" .. A group of workers in New York did cytological e~~inations 
of the smears of surgical castrates under estrogen and proges-
terone therapy. They found that the cell types are often more 
highly proliferated than usual in the luteal phase of the normal 
menstrual cycle. It was not an infrequent finding in patients 
under hormone therapy that some parts of the endometrium shovled 
more marked secretory c~~ges tr~n others. 
The endometrial specimens ,..,rere taken t1tJO ,..,reeks after the 
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commencement of progesterone therapy, and the histological 
findings were classified into the following four groups. 
(1) Proliferative changes only; 
(2) Minimal evidence of secretory change. Several glands 
exhibited no evidence of secretory change. whereas gome of the 
glands show subnuclear vacuolization with central position of 
nuclei; 
(3) Early secretory changes (delayed for the time of 
administration of progestational agents - 14 days). Practically 
all glands show the follo,,,ing features: a. subnuclear vac-
uolization, b. central position of the nuclei, c. supranuclear 
vacuolization, d. minimal evidence of accumulated secretion, 
e. relatively sharp nuclear border at the gland lumen, and f. 
early tortuosity of the glands; 
(4) Late secretory ct~nges (compatible with the late 
luteal changes of the normal menstrual cycle). Practically all 
glands show the following features: a. basal position of the 
nuclei; b. supranuclear vacuolization of the cytoplasm; c. 
warked accumulation of glandular secretion; d. loss of sharp 
cellular borders with Ilmelting" of the cytoplasm into the gland 
lumen and; e. well-developed. tortuosity of the gland. 
The 19-nor steroids have been widely used for OVUlation 
inhibition. Twenty day courses of the 19-nor steroid combined 
with an estrogen are currently being employed. There have been 
several reports about the endometrial char~es induced by the cyclic 
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administration of these compounds. With norethynodrel there 
is a very early appearance of glandular secretion similar to 
that seen in the early part of the normal luteal phase. Ro'Y'-
ever, after the appearance of intraepithelial vacuolization. 
the glands cease to progress and instead become small, involuted, 
and inactive in appearance. The stroma becomes markedly ede-
matous, with variable degrees of pseudo-decidual reaction. Rice-
Wray and others have studied the effects produced by the cyclic 
a~ministratial of norethindrone, and also emphasize the regres-
sive changes and irregularity of glandular secretion. VHth 
both compounds advanced atrophy has been observed. Surpris-
ingly, these endometria have a remarkable capacity to rebound 
imnlediately to functional and histologic normalcy once treat-
ment is stopped. 
Some of the events which take place during the normal 
cyclic evolution of the endometrium are as follows: glandular 
gro\lrth and tortuosity increase gradually reaching a maximum 
in the last quarter of the cycle. Secretory changes which 
begin on day 16, reach a peak on day 19 and 20, and then regress 
rapidly during the next two days. In the meantime stromal edema 
makes its appearance and pseudodecidual cranges become apparent. 
The sequence of events during therapy with norethynodrel is 
glandular regression iflhich seems to appear by day 14-16 and 
glandular regressive changes are far advanced by day 21. There 
is an almost complete disappearance of secretion by day 19-21 
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except in an occasional isolated gland. Stromal edema is quite 
marked from the outset and becomes intense at day 19-21. Pseu-
dodecidual change begins to appear about day 21, and remains 
patchy and low in its degree of development. This is a reaction 
markedly similar to tr~t of progesterone. 
j 
:Barnes states that such im:portant differences between the 
myometrium of one area contrasted with the myometrium of another 
area indicates that the uterus throughout most of pregnancy can-
not act as a unit. In contrast to the remainder of the myomet-
rium, the muscle benea.th the placenta apparently has a relative 
paralysis, a factor which may contribute to the fact that pre-
mature separation of the placenta is a comparatively rare acci-
dent rather than being a common place cliC1.ical phenomenon. In 
seeking an explanation for such differences, it would be quite 
logical to postulate that the placenta itself contributed the 
differentiating factor and that some placental ingredient per-
meated the myometrium locally and altered its chemical composition 
and hence its contractile ability. 
Since it has been demonstrated in the estrogen treated 
animal that the administration of progesterone will elevate the 
resting membrane potential as well as the total tissue potassium 
of the myometriu.rn, the postUlate has been advanced that placentally 
produced or stored progesterone reaches the cells of the adjacent 
myometrium in greater concentration than it reaches the rest of 
the myometr~~ contributing to this relative paralysis. This 
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hypothesis gains support from the recent documentation of the 
effect of progesterone on other huraan smooth muscle. It has 
suffered, however. from the fact that endogenous progesterone 
has never been recovered from the myometrium by any of the 
previously available techniques. Zander makes the specific 
statement that 11 it has never been possible to demonstrate 
nonlabeled progesterone or either of the A4_ 3- ketopregnene-
aI-one isomers in the target tissues, uterine muscles, and 
mucosa. II Using labeled progesterone, Davis and Plotz and 
Zander indicated that only a very limited amount of admin-
istered hormone is present in the muscles (eleven to eighteen 
weeks of pregnancy). 
Using gas-liquid phase chromatography, a technique has 
been developed for measuring tissue progesterone levels. 
Because this procedure requires fewer preliminary steps in 
purification and extraction, the placental levels found have 
been approximately twice those previously reported. and human 
myometrium from the term or near-term pregnant uterus has been 
found to have a concentration of progesterone varying from 
0.05 to 0.63 micrograL~s per gram wet weight tissue. 
Norethynodrel, a 19-nortestosterone derivative, has 
three main properties: (1) Progestational action when admin-
istered orally; (2) Inherent estrogenic effects and (3) Inhi-
bition of the pituitary gland. It has a unique action on the 
endometrium. It has been thOl~ht to exert a progesterone effect 
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on the human endometrium without estrogenic priming, although 
it has been uncertain whether all components of the endometrium 
reacted similarly to the compound. 
The following experiments were done on normally ovulating 
12 
patients: Ten patients were given 10 mg. daily from the 4-24 
day of the cycle. ]'or the most part, the glands were arrested 
in the early follicular phase, with some showing slight dila-
tat ion in some patients with normal ovulatory cycles. The 
glands were lined with either high or low columnar epithelium, 
with a minimum amount of secretion. The cytoplasm stained 
poorly. The stroma was cellular, with sOme edema. There were 
some hemorrl~ic areas. Five patients were given 10 mg. daily 
from 12-30 days of the cycle. The response of the endometrium 
was different when norethynodrel was started (at) near the mid-
cycle. The glands, arrested at the late proliferative phase, 
became dilated and cystic. The epithelium was flattened be-
cause of the intraluminal pressure. The stroma was markedly 
edematous. There "lere no changes in the blood vessels. 
Even though the endometrial glands are arrested in the 
early proliferative phase, treatment of patients ,,,ith secondary 
amenorrhea will result in withdrawal bleeding in most cases. 
Norethynodrel appears. therefore. to exert es trogen and proges-
terone effects on the endometrium. This effect is limited to 
the strorr.a. and less so to the epithelium. 
,i 
Goldzieher says that perhaps the greatest clinical concern 
21 
about synthetic progestational steroids has been the possibility 
of masculinization of female fetuses in mothers treated early in 
pregnancy for threatened or habitual abortion. Unfortunately, 
the statistical bias inherent in the collection of "anecdotal fl 
data makes it difficult to interpret the results. Any conclusion 
of the causal relationship between hormonal therapy and fetal 
masculinization based on this ty-pe of information may result in 
another expJnple of post hOc' fallacy. Several instances of 
clitoral hypertrophy have been observed by the author in new-
bOr!l i:nfants of mothers who received no hormone thera.py. Other 
cases of maSCUlinization have been reported in women who have 
received only stilbestrol, an estrogen which is not even a 
steroid. Such observations argue more for spontaneous occur-
rence than for any causal relationship_ It therefore, seems 
not improbable t~~t fetal anomalies in women treated with 
synthetic progestins reflect the current therapeutic vogue 
rather than any causal relationship between the steroid and the 
anomaly. To date, no case of human fetal masculinization in 
women treated \'dth medroxyprogesterone has been reported despite 
the widespread use of this material. 
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REVIEW OF CASES OF POSSIBLE MISSED ABORTION 
FOLLOWING TREATl\iJENT OF T:a:B:ElATENED ABORTIG1T 
WITH PROGEST.ATlm~AL AGEt-ITS 
In the treatment of threatened abortion with various 
progestational agents and progesterone some cases of what 
appear to be missed abortions have occurred. These patients, 
after being treated folloidng an episode of vaginal bleeding 
and a period of lov,Ier abdominal cramping, have been observed 
to show discontinuation of increase in the size of the uterus 
and of the other signs of pregnancy that were present prev-
iously. It has been postulated that the treatment with uro-
gestational agents may in some unexplained manner lead to the 
death of the fetus in utero, or that the fetus is already dead 
and the agents affect the uterine motility. The fetus is 
retained like tr.a.t of a missed a.bortion to be terminated by 
natural expulsion or dilatation and curettage. The following 
consists of a series of cases reported. by various doctors in 
Omaha, Nebraska. 
Case 1 
A 30 year old Negro female, para 3-1-4-4, ~~ about 
4-2-62 was admitted to UNH on 7-5-62 with the chief complaint 
of vaginal bleed.ing, uterine cramping a.nd possible passage of 
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tissue. She was treated with bedrest and Depo-Provera 75 mgm. 
I.lil. She was given 100mgm. of the Depo-Provera on the follow-
ing d.ay. The vaginal bleeding and cramping gradually subsided. 
A past history revealed menarehe at 13 years old. regular 28 day 
menstrual cycle with no dysmenorrhea. In 1948 she had a term 
baby, 1953 - 8 month gestation, 1956 - term, 1957 - aborted at 
6-7 weeks, 1959 - aborted at 3 months, 1960 - term, 1961 -
aborted at 3 months. On 7-10-62 she again complained of cra~pYt 
aching pain belo,,, the umbilicus and extending laterally \.,ith 
lumbar region pain. She had a pinkish vaginal discharge. She 
began to flow again on 11-10-62 lasting three days and spotted 
until 12-5-62 at which time she was bleeding heavily. She was 
considered a missed abortion after being seen in the emergency 
room and a D and C was done. The pathological report showed a 
piece of cotyledon and hyalinized necrotic material 
Case 2 
A 30 year old para 3 gravida 7 abortions 3 with Uv~ 
on 8-21-62. She was first seen on 12-7-62 with an episode of 
profuse vaginal bleedi~~ followed by spotting. She was given 
Provera. On 1-4-63 the uterus was the size of 3-4 months ges-
tation. There was no quickening and occasional bleeding occurred. 
On 1-29-63 there still was no growth of the uterus. At this time 
Provera was stopped. She no longer felt pregnant. On 2-18-63 
the uterus \-ras still the 3-4 month gestation size. The fibrinogen 
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level was 250 mg.% on 2-14-63 and 350 mg.% on 2-27-63. A DandC 
was done on 3-2-63. Pathology report showed a macerated fetus, 
about 8 weeks gestation with a necrotic placenta. 
Case 3 
A 39 year old. white female. para 0000, married 19 years, 
with L~~ on. 12-10-62. She has had a regular 28 day menstrual 
cycle with bleeding lasting three days since menarche. A frog 
test was positive in January. She began to spot in early Feb-
ruary_ About seven days later a flow like a normal menstrual 
period occurred a~d lasted three days. She was given a pro-
gestational agent and the bleeding stopped. In ~2Ich there was 
no increase in uterine size, and the pregnancy test was negative. 
An abdominal hysterotomy was done on 3-12~63. The material 
removed was placental along with a 2 month gestation fetus -
both atrophic and fibrous. 
Case 4 
A 43 year old white female became pregnant after a long 
history of i~Jertility. She began to bleed vaginally and was 
placed on Depo-Provera 100 mgm. I.1-1. on August 31, at which time 
she was also taking sulfa. She received Depo-Provera again on 
November 17, November 24, and December 8. She had passage of 
bloody mucus on January 30. 1963. Last fetal movements were 
noted on January 29. On 4-5-63 a D and C was performed a~d 
ischemic necrosis in decidual tissue was found. Past history 
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involved two abortions in 1960 and 1961. 
Case 5 
A 27 year old white female para lOll, L:!<1P 12-62, EDC 
9-15-63 with thrombocytopenic purpura and a history of a mis-
sed abortion in 1960 with a D and 0 following 5 weeks of 
bleeding. On 2-5 the fundus measured 8-10 cm. on 2-25 she 
was bleeding vaginally, the cervix was closed, fundus at 
10 cm and she ,\18.$ placed an Depo-Provera 100 mgm. r .14. On 
3-13 the fundus '''as llcm and she ~las again given 100 mgm. 
of Depo-Frovera. On 3-27 - fundus 12 cm. 1;:i th one episode 
of spotting. She ,1fas given Depa-Provera 100 mgm. On 4-8 
fundus 12 cm. - another 100 mgm. of Depo-Provera. On ~~22 
there "las questionable uterine enlargement. She ~las consid-
ered a missed abortion. The pregnancy test became negative 
on 4-30. A D and C ,\,laS done on 5-3. 
Case 6 
A 27 year old. para 1001 - LMP 1-7-63. She '''as seen on 
4-9-63 for vaginal spotting. On 4-23 she W8.S trea,ted "lith 
Ent CVP plus Prover~. The uterus had not increased in size 
since the previous visit. She was also on Deluteval twice 
a week through ~~y. On 5-30 she r~d an episode of severe 
vaginal bleeding with possible passage of tissue. The uterus 
was estimated to be the size compatible with two months ges-
tation. A D and C was done and necrotic decidual and placental 
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tissu.e "las found without a fetus. 
Case 7 
A" 26 year old, para 1021, LMP December 1959. with a 
history of previous abortions in l-1a,rch 1959 and August 1959. 
In December she thought that she was pregnant and was given 
15 shots of progesterone in an attempt to prevent another 
abortion. She ha.d an episode of bleedil"..g in April, but it 
d.id not seem like a period. She r...a.d complete amenorrhea since 
April 18, 1960. She didn't feel good a..'1d was given thyroid. 
extract 1 grain for one year. She "ras considered a possible 
missed abortion because of the "shots. 1I In October the frog 
test was negative. She "Jas given progesterone and bled on 
the t\tJelfth day after injection. On 10-27-60 she bled and 
passed tissue. A D and C "las done. The pathology report 
indicated an incomplete abortion with fibroses and degeneration 
in the placenta. 
Case 8 
A 22 yet>..I' old ",hite female,para. 0110, L~lP 4-27-62, 
Ene 2-3-63. She was seen on 8-2-62 for pressure on the bladder, 
cramping and passing blood and a large clot. She ';las ~out on 
40 mgm. orally of Provera the following day. She had SOme 
bleedir>..g every day since then \vi th occasional cramping. She 
stated tlmt the time of bleeding coincided with the fourth 
period since her LMP. At the time of the second period she had 
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cre-nrps but no bleeding. Pregnancy tests were negative on 
8-13-62. A D and C was done on 8-17-62 and a macerated fetus 
and placenta. were removed. 
Case 9 
A 26 year old white female. para 3002, 1M? 9-5-62. She 
noticed spotting since 11-22-62. She was treated with 100 mgm. 
of Depo-Provera. She was seen on 1-5-63. The uterus which 
should have been the size of four months gestation was the size 
of a. two month gestation. She no longer felt pregnant. She 
was diagnosed as a missed abortion. A D and C was done on 
1-22-63 sho\tling degenerated decid.ual tissue and chorionic villi. 
The following cases are presented to illustrate the pro-
duction of' what appears to be a. missed abortion after treatment 
of a threatened abortion with agents other than progestational 
agents. 
Oase 10 
A 23 year old \tlhi te female para lOll, Iu\rjp 11-1l.J-57. She 
felt quickening on 3-2-58. On 3-9 she began spotting following 
void.ing. She \-!as placed on. Lutrexin 2000 and 3-4 xd. The 
bro\li'11ish spotting recurred on 1+-4. On 5-9 ther~ ",as no evi-
dence of uterine gro\ith since the previous month. On 5-29 
a D and E was performed. There was escape of bro1!mish amniotic 
flu:i.d and minimal bleeding. no fetus and evidence of hydropic 
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degeneration. Microscopic examination showed. pla.centa. decidual 
and endometrium of early pregnancy with hydatiform deformity of 
villi. 
Case 11 
A 37 year old \'(I1".i te female, para 7007, LlvIP 4-14-63, EC 
1-21-64, t'(lith a mens trual cycle of 20-23 days las ting four cla.ys. 
On 7-19-63 she was hospitalized as a threatened abortion. She 
was placed on Stilbestrol 25 mgm. three times a day, DUO-aVp 
t"Jice a day. On 8-22-63 there was no bleeding or uterine 
enlargement. She "ras diagnosed as a. missed. abortion. A 
D and C wa.s done on 8-30 and necrotic placental and decidual 
tissue Was found. 
Case 12 
A 43 year old white female, para 2012, k'~ 2-7-55. She 
1I?as seen on 4-15-55 after spotting for one week. At this time 
the pregnancy test was positive. She was placed. on 25 mg. 
Stilbestrol every four hours. On 6-13 the uterus was soft 
and. irregular but not the size of a four month pregnancy. The 
pregnancy test ''las negative. She l:'.ad spotting and cramping on 
7-15 which lasted until 8-11. A D and E was done on 8-13 and 
it sho,"red a. placenta with necrosis, hehlorrb.age and acute infla-
mmation and she was considered a missed abortion. Her past. his-
tory included a. cesearean section done for placenta previa in 
1949. and a. miscarriage in 1952, a.lso, two possible miscarriages 
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in :/'.lB.rch 1953 and July 1953. A D and C Was done for a 
hydatitiforn mole in August 1953. 
The majority of cases were treated, at the time that 
s-potting \'las noted, 'tli th a progestational agent in the attempt 
to salvage the pregp.ancy from aborting. The bleeding usually 
subsided \>li thin a short period of time. However, instead of 
proceeding on to a full term viable pregnancy the growth of 
the uterus and the other signs of pregnancy subsided and within 
four to ten weeks bleeding usually recurred and a dilatation 
and curettage wa.s done on the basis of a diagnosed missed abor-
tion. The ages and parities of the patients differed. Some of 
the patients had histories of previous a.bortions as well as 
missed abortions. Very fe'V! of them were on any other medication 
besides the progestational agents ee.rly in the pregnancy or a.t 
the time of treatment. According to the accepted definition of 
missed abortion, it is difficult to determine whether the treat-
ment of a threatened abortion, as occurred in the above ca.ses, 
with progesterone could cause a missed abortion to take place. 
The evidence seems to support the suspicion that it does pos-
sibly occur. Further research into the subject is necessary be-
fore any proof against the use of the progestational agents in 
such cases can be considered. 
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SUMMARY 
The danger in the use of :9X'ogesta.tional agents in the 
treatment of threatened abortions is considered. A hypothesis 
is put forth that the type of treatment may in some way lead 
to the development of a missed abortion. T\tlelve cases are 
reviewed in which treatment ""ith a progestational agent was 
begun when the patient began to spot early in the pregnancy_ 
In each of these cases, in the ensuing weeks, a missed abortion 
developed and a D and C was necessary for removal of the necrotic 
products of gestation. No direct proof Was set forth in the 
above thesis. This is considered only as a possibility to be 
considered in the use of progestational agents. As a preview 
to the case reports the various aspects of missed abortion were 
reviewed. A missed abortion was defined, according to Eastman, 
as the retention, two months or more after its death, of an 
early intra-uterine pregnancy. There were no decisions as to 
the etiology. The relationship between blood levels of proges-
terone and estrogen along. "J1th the urinary excretion of preg-
nanediol and estriol before a~A a£ter uterine death was examined. 
Several workers have noticed the fall in fibrinogen levels of 
women carrying dead fetuses. They have also noted tha,t in spite 
of high levels of fibrinolysins the fibrinogen levels did not 
fall in direct proportion. The danger occurred during labor 
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when cases of severe bleeding did result. 
The general properties and area of production in the body 
of progesterone was cited. The action of progesterone in preg-
nancy and its effects on the endometrium were discussed. The 
actions of norethynodxel were included here. 
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COUCLUS I 01T 
A hypothesis is presented in this thesis that the use of 
progestational agents in treating t:b..reateneo. abortions may be 
responsible for its developing into a missed abortion. These 
agents, in some way. may be the cause of death. of the fetus and 
decrease in the size of the pregnant uterus. This is not to be 
used as proof in any way that this occurs. but is written to 
increase the index of suspicion when these drugs are used. 
Further extensive research, using controls, is necessary for 
proof that there is a direct relationship between the use of 
progesterone and the development of a missed abortion. 
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